Carbamylome analysis reveals regulatory roles for lysine carbamylation in β-cell glycolytic and insulin-processing enzymes

In type 1 diabetes (T1D), insulin-producing β cells are destroyed by an autoimmune response driven by pro-inflammatory cytokines. The signaling of these cytokines is partially mediated by post-translational modifications, such as phosphorylation and acetylation. However, the role of other post-translational modifications in β-cell cytokine signaling represents an important knowledge gap. In the context of autoimmune diseases, lysine carbamylation has gained attention for its role in pathogenesis. Here, we investigate possible roles of carbamylation in T1D. We found that pancreata from the T1D model, non-obese diabetic (NOD) mice, at pre-diabetic stage (8-9 weeks old) exhibit 11% carbamylation-positive β cells, whereas non-diabetic CD1 mice have only 5%. Proteomics analysis of the MIN6 insulin-producing cell line treated with a cocktail of three pro-inflammatory cytokines IFNγ + IL-1β + TNFα identified 284 carbamylated peptides from 222 proteins regulated by the cytokine treatment. Integration of carbamylation and acetylation provided a deep view of the cytokine-regulated PTMs and potential points of interplay. A functional-enrichment analysis revealed that carbamylation was enriched in pathways related to autoimmune diseases, metabolism, DNA replication, and protein translation. Moreover, functional testing demonstrated that carbamylation inhibits the glycolytic enzyme aldolase A and the insulin-processing enzyme carboxypeptidase E, identifying a possible role for cytokine-induced β-cell dysfunction. In summary, NOD mice have more carbamylated β cells than CD1 mice, and pro-inflammatory cytokine treatment regulates protein carbamylation in MIN6 cells. These data identified carbamylation as a potential regulatory mechanism for β-cell metabolism and insulin production in insulitis.

Authors

Institutions

Publication Details

Journal
Biochemical Journal
Published
2026-11-17
DOI
https://doi.org/10.1042/bcj20260414
Citations
1
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
1.73

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Carbamylome analysis reveals regulatory roles for lysine carbamylation in β-cell glycolytic and insulin-processing enzymes

Christopher V. Rao, Bobbie‐Jo Webb‐Robertson, Raghavendra G. Mirmira, Emily Kristen Sims et al.
1 citations
Biochemical Journal
Diabetes and associated disorders
1.73
article

Carbamylome analysis reveals regulatory roles for lysine carbamylation in β-cell glycolytic and insulin-processing enzymes

Christopher V. Rao, Bobbie‐Jo Webb‐Robertson, Raghavendra G. Mirmira, Emily Kristen Sims, Ernesto Satoshi Nakayasu, Mereena George Ushakumary, Panshak Dakup, Youngki You, Lori Sussel, Weijun Qian, Gina M. Many, Fangjia Li, Hanna E. Walukiewicz, Ivo Díaz Ludovico, Zhiwei Xu, Marina A. Gritsenko, Hyeyoon Kim, Alan Wolfe, G C Clair
article en
1 citations

Abstract

In type 1 diabetes (T1D), insulin-producing β cells are destroyed by an autoimmune response driven by pro-inflammatory cytokines. The signaling of these cytokines is partially mediated by post-translational modifications, such as phosphorylation and acetylation. However, the role of other post-translational modifications in β-cell cytokine signaling represents an important knowledge gap. In the context of autoimmune diseases, lysine carbamylation has gained attention for its role in pathogenesis. Here, we investigate possible roles of carbamylation in T1D. We found that pancreata from the T1D model, non-obese diabetic (NOD) mice, at pre-diabetic stage (8-9 weeks old) exhibit 11% carbamylation-positive β cells, whereas non-diabetic CD1 mice have only 5%. Proteomics analysis of the MIN6 insulin-producing cell line treated with a cocktail of three pro-inflammatory cytokines IFNγ + IL-1β + TNFα identified 284 carbamylated peptides from 222 proteins regulated by the cytokine treatment. Integration of carbamylation and acetylation provided a deep view of the cytokine-regulated PTMs and potential points of interplay. A functional-enrichment analysis revealed that carbamylation was enriched in pathways related to autoimmune diseases, metabolism, DNA replication, and protein translation. Moreover, functional testing demonstrated that carbamylation inhibits the glycolytic enzyme aldolase A and the insulin-processing enzyme carboxypeptidase E, identifying a possible role for cytokine-induced β-cell dysfunction. In summary, NOD mice have more carbamylated β cells than CD1 mice, and pro-inflammatory cytokine treatment regulates protein carbamylation in MIN6 cells. These data identified carbamylation as a potential regulatory mechanism for β-cell metabolism and insulin production in insulitis.

Biochemical Journal
Pacific Northwest National Laboratory (US), University of Illinois Urbana-Champaign (US), Loyola University Chicago (US), University of Chicago (US), Indiana University School of Medicine (US), University of Colorado Anschutz Medical Campus (US)
U.S. Department of Energy, Battelle, Human Islet Research Network, National Institute of Diabetes and Digestive and Kidney Diseases, Pacific Northwest National Laboratory
Good health and well-being
Openalex Percentile: Top 25%
Diabetes and associated disorders
1.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon